Indivior's Chief Scientific Officer Stock Sale: Worry?
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
Compare daily and long-term volatility across major coins to inform allocation and risk controls in your portfolio.
20,930 articlesA large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
President Donald Trump announced a peace deal with Iran, triggering sharp moves in oil, stocks, and currencies as inv...
A coalition of about 1,000 foundations unveils a nationwide effort to remind Americans how charities support communit...
The title insurance market posted $4.5 billion in premiums in Q1 2026, up from $3.9 billion a year earlier, with clai...
BrokerBot has closed a fresh seed round led by Grand Ventures and Second Century Ventures as the AI platform scales t...
A billionaire space founder argues a childhood marshmallow test predicts long-term wealth outcomes, and that your car...
When an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
A landmark massive multi-billion-dollar industry merger is reshaping how investors view McCormick, nudging it from a ...
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Investors and households are bracing for the Federal Reserve's policy decision, with potential moves on borrowing cos...
At VivaTech in Paris, Jeff Bezos argues AI will expand the labor force, not shrink it. The piece explores how this vi...
Compass is broadening its northern Arizona footprint with a new leadership lineup in Flagstaff, aiming to capture lux...